| Dr Muna Ibrahim Osman, DNP FNP-BC | |
|
721 M St Ne Ste 105, Auburn, WA 98002-4503 | |
| (253) 766-1161 | |
| (253) 804-5565 |
| Full Name | Dr Muna Ibrahim Osman |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Primary Care |
| Location | 721 M St Ne Ste 105, Auburn, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578031266 | NPI | - | NPPES |
| Entity Name | Molina Healthcare Of Washington Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912235060 PECOS PAC ID: 1850427527 Enrollment ID: O20100405000336 |
News Archive
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.
Many lives have been lost to the severe pneumonic disease COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), during the ongoing pandemic. The reason for the critical lung injury that results in a fatal outcome in a significant minority of patients has been supposed to be the dramatic oversecretion of pro-inflammatory cytokines and chemokines triggered by the virus.
Kaiser Health News staff writer Jay Hancock, working in collaboration with USA Today, reports: "Congratulations. You bought insurance through one of the online Affordable Care Act exchanges, possibly after days or weeks of trying to get the site to work. Don't relax. Joining the plan is only the first challenge. Now you have to understand it. Policies sold through the online portals - to more than 3 million people so far - cover essential benefits and put a cap on your out-of-pocket medical costs. But you need to follow the rules" (Hancock, 2/17).
A vaccine to protect humans from a bird flu pandemic is within reach after a new discovery by researchers at the University of Melbourne, Australia
An examination of the treatment received by patients with myocardial infarction (heart attack) at 80 hospitals in Quebec indicates that those who received either primary percutaneous coronary intervention (PPCI; such as angioplasty) or fibrinolysis (administration of medication to dissolve blood clots) beyond the times recommended in international guidelines had a significantly increased risk of death within 30 days, along with an increased risk of the combined outcome of death or readmission for heart attack or heart failure at one year, according to a study in the June 2 issue of JAMA.
› Verified 2 days ago
| Entity Name | Bastion Health Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750921193 PECOS PAC ID: 1557790896 Enrollment ID: O20200407002530 |
News Archive
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.
Many lives have been lost to the severe pneumonic disease COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), during the ongoing pandemic. The reason for the critical lung injury that results in a fatal outcome in a significant minority of patients has been supposed to be the dramatic oversecretion of pro-inflammatory cytokines and chemokines triggered by the virus.
Kaiser Health News staff writer Jay Hancock, working in collaboration with USA Today, reports: "Congratulations. You bought insurance through one of the online Affordable Care Act exchanges, possibly after days or weeks of trying to get the site to work. Don't relax. Joining the plan is only the first challenge. Now you have to understand it. Policies sold through the online portals - to more than 3 million people so far - cover essential benefits and put a cap on your out-of-pocket medical costs. But you need to follow the rules" (Hancock, 2/17).
A vaccine to protect humans from a bird flu pandemic is within reach after a new discovery by researchers at the University of Melbourne, Australia
An examination of the treatment received by patients with myocardial infarction (heart attack) at 80 hospitals in Quebec indicates that those who received either primary percutaneous coronary intervention (PPCI; such as angioplasty) or fibrinolysis (administration of medication to dissolve blood clots) beyond the times recommended in international guidelines had a significantly increased risk of death within 30 days, along with an increased risk of the combined outcome of death or readmission for heart attack or heart failure at one year, according to a study in the June 2 issue of JAMA.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Muna Ibrahim Osman, DNP FNP-BC 721 M St Ne Ste 105, Auburn, WA 98002-4503 Ph: (253) 766-1161 | Dr Muna Ibrahim Osman, DNP FNP-BC 721 M St Ne Ste 105, Auburn, WA 98002-4503 Ph: (253) 766-1161 |
News Archive
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.
Many lives have been lost to the severe pneumonic disease COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), during the ongoing pandemic. The reason for the critical lung injury that results in a fatal outcome in a significant minority of patients has been supposed to be the dramatic oversecretion of pro-inflammatory cytokines and chemokines triggered by the virus.
Kaiser Health News staff writer Jay Hancock, working in collaboration with USA Today, reports: "Congratulations. You bought insurance through one of the online Affordable Care Act exchanges, possibly after days or weeks of trying to get the site to work. Don't relax. Joining the plan is only the first challenge. Now you have to understand it. Policies sold through the online portals - to more than 3 million people so far - cover essential benefits and put a cap on your out-of-pocket medical costs. But you need to follow the rules" (Hancock, 2/17).
A vaccine to protect humans from a bird flu pandemic is within reach after a new discovery by researchers at the University of Melbourne, Australia
An examination of the treatment received by patients with myocardial infarction (heart attack) at 80 hospitals in Quebec indicates that those who received either primary percutaneous coronary intervention (PPCI; such as angioplasty) or fibrinolysis (administration of medication to dissolve blood clots) beyond the times recommended in international guidelines had a significantly increased risk of death within 30 days, along with an increased risk of the combined outcome of death or readmission for heart attack or heart failure at one year, according to a study in the June 2 issue of JAMA.
› Verified 2 days ago
Deborah Ann Coughlin, ARNP: AP30007936 Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1340 M St Se, Suite A, Auburn, WA 98002 Phone: 253-735-2777 Fax: 253-735-4153 | |
Mrs. Alicia Austria Paraiso, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 20 Auburn Ave, Auburn, WA 98002 Phone: 206-205-6855 Fax: 206-296-8403 | |
Mrs. Oanh Thi Lam, PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 31510 120th Ct Se, Auburn, WA 98092 Phone: 315-399-7573 | |
Ms. Lucie Mckee, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 E Main St, Suite 100, Auburn, WA 98002 Phone: 253-939-9654 Fax: 253-939-6549 | |
Linda Josephine Matthews, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 29224 120th Way Se, Auburn, WA 98092 Phone: 206-249-5440 | |
Ms. Jennifer Christine Drake, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4240 Auburn Way N, Sound Mental Health, Auburn, WA 98002 Phone: 253-876-8900 Fax: 253-876-8910 | |
Dixie Leah Reynolds, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 202 N Division St Ste 202, Auburn, WA 98001 Phone: 253-876-8088 |